Hetero Drugs Ltd
Tofacitinib (11mg)
Jakura-XR Tablet is used to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
Tablet ER
Jakura-XR Tablet may be prescribed by itself or in combination with another medicine. The tablets can be taken with or without food and it is best to take them at the same time each day. Your dose will depend on your condition and what other medicines you are taking. You should use it as your doctor tells you to. Do not stop taking this medicine unless your doctor tells you to because your condition could get worse.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jakura-XR Tablet may be taken with or without food, but it is better to take it at a fixed time.
upper respiratory tract infections headache diarrhea nasopharyngitis
Consuming alcohol with Jakura-XR Tablet does not cause any harmful side effects.
Jakura-XR Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Jakura-XR Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Jakura-XR Tablet is a Janus kinase inhibitor. It works by blocking the action of the enzyme Janus kinase. This decreases the activity of the immune system and inflammation associated with rheumatic diseases and ulcerative colitis.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jakura-XR Tablet may be taken with or without food, but it is better to take it at a fixed time.
Inform your doctor about any pre-existing liver conditions before starting Jakura-XR Tablet. This is because in some cases, Jakura-XR Tablet may increase liver enzyme levels. Therefore, your liver function must be checked before starting Jakura-XR Tablet. While Jakura-XR Tablet can be prescribed to patients with mild to moderate liver dysfunction, it should not be given to those with severe liver impairment.
Jakura-XR Tablet may increase the risk of developing certain cancers (lymphoma and other cancers including skin cancers) by impacting the immune system. Therefore, inform your doctor if you have or have had any history of cancer.
Jakura-XR Tablet is approved for use in individuals with moderate to severe rheumatoid arthritis. It's an inflammatory condition that affects the joints. It's prescribed when previous treatments haven't been successful or are not suitable. It can also be used earlier in treatment if a patient doesn't respond well to the prescribed drugs, and it may be used alone or alongside other medications like methotrexate.
Jakura-XR Tablet usually takes about 2 to 8 weeks before you start feeling better, and it can take 3 to 6 months to experience the maximum effect of this medication.
Blood tests may be required before or while taking Jakura-XR Tablet. These tests are used to check for low red blood cell count (anemia), low white blood cell count (neutropenia or lymphopenia), high blood fat (cholesterol) or high levels of liver enzymes. This helps ensure treatment with Jakura-XR Tablet is safe.
Jakura-XR Tablet influences the immune system, making you less able to fight infection and increasing the risk of serious infections such as tuberculosis. It can also lead to a higher risk of infections caused by severe fungal, bacterial, or viral spread across the body. These infections can be life-threatening and even fatal. Therefore, it is crucial to seek treatment in a hospital for these infections.
No, you should not take tocilizumab alongside Jakura-XR Tablet. Both medications affect the immune system, and combining them together increases the risk of infection and potentially further complications.